ArticleTherapeutics and clinical risk management2015

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study.

Sona Frankova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.